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Abstract
Epiretinal membranes (ERMs) are contractile membranes that occur on the inner
surface of the retina and can lead to significant visual impairment when located at the
central retina. Recent advances in vitreoretinal surgery have greatly improved the
safety and efficacy of microsurgical intervention at the retinal surface level. Today,
vitrectomy and membrane peels are considered the treatment of choice for most
patients with ERMs that create significant visual symptoms. Nevertheless, possible
complications such as accelerated cataract formation, recurrence of ERM and retinal
detachment may withhold the choice of surgical intervention. Additionally, in some
cases, simple observation may be advised. In view of surgery, controversies regarding
techniques such as those related to an internal limiting membrane peel and the use of
dye still exist. In this chapter, we cover current surgical techniques for ERM removal,
their expected results, possible complications, as well as a guide for possible case
selection.
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1. Introduction
1.1. Classification
The disease entity of epiretinal membrane (ERM) proliferation was first described in 1865 by
Iwanoff [1]. It is caused by the proliferation of avascular cellular sheets on the inner retinal
surface and along the internal limiting membrane (ILM), which possesses contractile proper‐
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ties and as a result, leads to variable visual symptoms and visual impairments, primarily due
to the mechanical distortion of the macular area. The condition's variable effect on vision is
determined primarily by the severity of the retinal distortion and the location of the membrane.
ERMs can be classified according to their underlying aetiology into: a) primary or idiopathic
ERMs (iERMs) [2], when no underlying causative factor or ocular pathology can be associated
with the membrane formation; b) secondary ERMs, which are commonly found in association
with retinal breaks and retinal detachment (RD), RD surgical repair, laser photocoagulation,
retinal cryopexy, proliferative vitreoretinopathy (PVR), retinal vascular diseases, intraocular
inflammation and ocular trauma [3-7]. Additionally, international literature describes rare
cases of secondary ERM formation associated with type-2 neurofibromatosis [8]. In addition
to the etiological classification, Gass proposed a clinical classification of ERMs based on
biomicroscopical findings [9], according to which ERMs can be differentiated into three grades:
a. Grade 0 membranes or cellophane maculopathy. Translucent membranes not associated
with retinal or visual distortion.
b. Grade 1 membranes or crinkled cellophane maculopathy. Membranes causing an
irregular wrinkling of the inner retinal surface due to the contraction of the overlying
membrane. Increased vascular tortuosity and perimacular vessels being pulled toward
the fovea are common findings.
c. Grade 2 membranes or macular puckers. Opaque and thick membranes that cause
profound retinal distortion and tractional phenomena. Cystic macular oedema, intrareti‐
nal haemorrhages, exudates, foveal ectopia and shallow localized retinal detachment can
be accompanying findings in biomicroscopy.
2. Epidemiology and pathophysiology
Idiopathic membranes and membranes associated with RD or retinal tears, as well as their
management, are the most prevalent clinical phenotypes of ERM proliferation [10]. The
prevalence of iERM in the general population is estimated to be approximately 6 to 7% [11],
with the disease's prevalence increasing significantly with age. Specifically, according to
epidemiologic studies, the prevalence of ERM formation is increasing from 2% under the age
of 60 years to 12 to 20% beyond the age of 70 [2, 10], while it is bilateral in 10 to 30% of cases
[11-12]. Nevertheless, lower prevalence rates have been recorded in Chinese populations [13].
Moreover, histopathological findings suggest the presence of iERMs in 1.7 to 3.5% of autopsied
eyes [12-14]. Regarding secondary ERMs, the disease incidence is 4 to 8% following surgical
management of rhegmatogenous RD [15-16] and 1 to 2% following precautionary treatment
of peripheral retinal breaks [17].
The proposed theories regarding the underlying pathophysiology of ERM formation have
been controversial; furthermore, the exact origin and type of cells that make up different types
of ERMs remains an area of debate [14, 18]. Nevertheless, the general consensus is that the
primary cell component in iERMs is of glial origin, more recently called laminocytes, while
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secondary ERMs predominantly consist of different cell types that do not originate in the
neuroretina, such as retinal pigment epithelial (RPE) cells, macrophages, myofibroblasts and
fibrocytes, depending on the causative ocular pathology [19-20]. Posterior vitreous detachment
(PVD), complete as well as partial, seems to play an important role in ERM pathogenesis.
Specifically, it is well documented that PVD is present in up to 90% of eyes with iERMs and
in fact, in all eyes with ERM formation associated with RD or retinal breaks [21]. It is therefore
believed that glial cells from the neuroretina migrate through breaks in the ILM occurring
during the PVD process and start to proliferate on the inner retinal surface, resulting in the
formation of iERMs [18]. According to another theory, residual vitreous on the retinal surface
following PVD may be related to the development of iERMs [22]. Nevertheless, iERM forma‐
tion is also known to take place in eyes without PVD. In these cases, different theories have
been proposed, including the migration of cells of glial origin through pre-existing ILM breaks
or due to ILM thinning [23]; additionally, the vitreous traction theory proposes that astrocytic
gliosis, commonly triggered by ischaemia and vitreous traction, can also occur in cases with
partial or anomalous PVD (vitreoschisis), or even in the absence of PVD due to the coexistence
of vitreous-retina attachment (complete or partial) with simultaneous vitreous movement,
which is facilitated by the natural liquefying process of the vitreous, ultimately generating
active vitreous traction and therefore, astrocytic gliosis [24]. On the other hand, the formation
of secondary ERMs that develop in association with retinal breaks, RD, cryopexy and laser
photocoagulation, most likely represents a form of mild PVR caused by the release of RPE cells
into the vitreous cavity and their subsequent proliferation on the retinal surface [25]. In their
recent work, Snead and colleagues [26], using surgically peeled membrane specimens and
normal cadaver globes, determined the principal cell populations that characterize different
types of ERMs, thus allowing for a clinical classification of ERMs based on their histopatho‐
logical characteristics, which reflect different aetiologies. Specifically, they concluded that
idiopathic ERMs are characterized by laminocytes and ILM, while the presence of laminocytes
both on the ILM surface and the posterior hyaloid membrane (PHM) in cases of PVD raised
the hypothesis that separation can likely occur due to the cellular activity of pre-existing
laminocytes at the vitreoretinal interface. In ERMs, secondary to RD, retinal tears, PVR, trauma
or intraocular inflammation, RPE cells, macrophages, lymphocytes and collagen were the
primary cell components indicating that these ERMs most likely represent a tissue repair
reaction. Furthermore, ERMs, secondary to PDR and vasoproliferative tumours, consisted
mainly of capillaries and acellular stromal tissue, and were therefore characterized as neovas‐
cular ERMs, with hypoxia likely being the main stimulus for their formation.
In addition, recent studies implementing novel immunohistochemistry and proteomics
techniques have attempted to elucidate the role of inflammatory cytokines and trophic factors
in ERM development and proliferation. Basic fibroblast growth factor (bFGF) supports the
survival and proliferation of glial cells and may play an important role in the ERM pathogen‐
esis [27]. Harada et al. [28] encountered increased reactivity and expression of the bFGF in the
majority of iERM and PDR-associated ERM cases studied. In accordance, similar results were
reported by Chen et al. [29]. Other studies stressed the role of the nerve growth factor (NGF)
and the transforming growth factors β1 and β2 (TGFβ1 and TGFβ2) in iERM formation and
their subsequent contraction [30-31]. Authors suggested that these trophic factors possibly
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induce the differentiation of glial cells into myofibroblasts, granting ERMs their contractile
properties [30-31]. Increased expression of the vascular endothelial growth factor (VEGF) has
also been reported in iERMs, though its exact role in the disease pathogenesis still remains
unknown [29, 32-33]. Furthermore, proteins such as apolipoprotein A-1, transthyretin, α-
antitrypsin, serum albumin and interleukin-6 have also been proposed to participate in the
pathogenesis of the disease [27, 34].
3. Natural course and associated symptoms
ERMs tend to remain stable or to present limited progression over time, with most patients
experiencing mild or no symptoms following the initial diagnosis, indicating that membrane
contraction possibly occurs at an early phase after its original formation and generally
stabilizes thereafter. According to the findings of the population based “Blue Mountains Eye
Study”, epiretinal membrane progression was encountered in 28.6% of cases, stability was
noticed in 38.8% of eyes, while 25.7% of cases regressed during a five-year follow-up period
[35]. Accordingly, former studies have supported the non-progressive character of the disease
[36-37], since only 10 to 25% of eyes seemed to show a significant decrease in visual acuity over
time, with variable rates of progression [2, 9]. In fact, previous reports suggest that less than
5% of ERM cases present visual acuity of 20/200 or worse [38-39]. Moreover, rare cases of
spontaneous ERM separation from the retina with associated visual improvement have also
been documented [9, 40].
ERMs are symptomatic only if the macular or peri-macular area is involved. In its mildest
forms, such as in cases of cellophane maculopathy, the disease is usually asymptomatic [38-39].
Symptomatic patients usually complain of decreased visual acuity (VA), metamorphopsia or
vague visual disturbances. Other less common symptoms include micropsia and monocular
diplopia [38-39]. In general terms, the extent of the visual effect of the disease is determined
mainly by the degree of the induced retinal distortion, the position of the membrane in
association to the macula, as well as its thickness and transparency. The decrease in VA can
generally be attributed to the filtering effect of the ERM that prevents light from reaching the
photoreceptors, the distortion of the retinal surface, as well as the macular oedema and the
associated vitreoretinal traction due to incomplete PVD, if present. The distortion of the retinal
surface due to ERM contraction, which in some cases can involve the entire retinal thickness,
is the primary cause for metamorphopsia, which is usually the leading and most disturbing
symptom of the disease.
4. Diagnosis
The diagnosis of the disease is primarily clinical, based on fundus biomicroscopy. In its mildest
form, ERM is detected only as a mild glistening light reflex from the inner retina. Fundus
examination or fundus photographs with a blue filter may facilitate visualization of very thin
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membranes [41]. In more advanced cases, wrinkling and/or striae of the retinal surface, as well
as retinal vessel distortion may be noticed during examination. Usually, the membrane itself
is invisible; nevertheless in advanced cases and particularly in cases of secondary membranes
associated with retinal breaks and RD, the ERM can be seen as a grey-whitish membrane that
obscures the visualization of the underlying retinal vasculature and retinal surface. Other
associated biomicroscopic findings may include PVD, small intraretinal and preretinal
haemorrhages, central macular oedema due to retinal vascular leakage, areas of whitening of
the inner retina due to axonoplasmic stasis secondary to ischaemia, foveal ectopia due to
macular traction and pseudoholes. A pseudohole is a commonly associated clinical finding
and is considered to be the result of the formation of a membrane defect accompanied by the
displacement of retinal tissue that occurs during the contraction of the ERM [9]. The Watzke-
Allen slit beam test is a useful clinical test that can differentiate between a pseudohole and a
true full-thickness macular hole [42]. In cases of a positive Watzke-Allen test, the patient will
perceive a “break” in the slit beam. The test is negative in the case of a pseudohole.
Optical coherence tomography (OCT) is the most sophisticated and contemporary imaging
modality in the diagnosis of ERMs. In OCT imaging, an ERM is typically demonstrated as a
hypereflective band over the retinal surface, while wrinkling of the retina is easily visualized
when present. Associated clinical entities, such as vitreomacular traction, macular oedema,
loss of the foveal pit and foveal ectopia due to ERM traction are also readily demonstrated
using this imaging technique (Figure 1). Moreover, OCT can easily differentiate between a
pseudohole and a true macular hole, and can also serve as a very useful tool in ERM preop‐
erative planning and in postoperative follow-up.
Figure 1. OCT image of an epiretinal membrane. In addition to the apparent thick membrane, the OCT scan reveals
considerable macular thickening and cystoid macular oedema. Notice the prominent vascular tortuosity (left) and the
obvious edge in the OCT scan of the membrane (right), which may be used for peeling initiation during surgery.
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In addition, fluorescein angiography (FA) is another adjuvant diagnostic test for ERM. Despite
the fact that it is usually not necessary to establish the diagnosis of an ERM, FA can be helpful
in assessing the extent of vascular distortion and detect the presence of vascular leakage and
macular oedema. ERM associated vascular leakage, when present, is typically irregular,
asymmetric and within the area of the ERM. It is also useful to exclude other lesions that may
share common clinical findings with ERMs, such as choroidal neovascularization and other
vascular diseases of the retina.
5. Surgical technique and instrumentation
The rationale of the technique for removing the ERM has not changed since 1972, when
Machemer introduced this procedure to vitreoretinal surgery. Machemer used a 23g bent
needle to remove the epimacular membrane after 17g pars plana vitrectomy. Despite the
continuous evolvement and development of surgical instrumentation, the technique today
remains practically the same. First, a three-port pars plana vitrectomy is performed. The ERM
is then peeled off with appropriate forceps. Dyes are often used to better visualize the
membrane. Sometimes, scissors are necessary for the dissection of highly-adhered membranes.
Several surgeons proceed to ILM peeling as a next step in order to minimize ERM recurrence.
In most cases, the operation finishes without the need for tamponade and mandatory posture.
In the following paragraphs, the steps of the procedure, as well as the necessary equipment
and adjuvants are described in more detail.
5.1. Vitrectomy
A three-port pars plana vitrectomy is the first step of the procedure, although there are some
reports in the literature regarding direct epiretinal membrane peeling without prior vitrectomy
[43-44]. A core vitrectomy is performed, followed by posterior vitreous detachment, if this is
not already present. This is done either actively with the vitreous cutter, or passively with a
flute needle, starting by elevating the posterior hyaloid membrane at the level of the optic disc.
Subsequently, the vitrectomy is completed with the cortex removal.
5.1.1. Microincision Vitrectomy Systems, MIVS
During the past number of years, most surgeons prefer small gauge vitrectomy systems and
thus, the procedure is sutureless and atraumatic. The systems that are broadly used for the
macula surgery are the 23G and the 25G, while 27G was also recently introduced [45]. The use
of either system depends primarily on the surgeon’s preference and they do not seem to affect
postoperative outcomes [46-49]. However, the wide acceptance of the microincision systems
indicates that these outnumber the 20-g system, offering shorter operating times, reduced
corneal astigmatism, diminished conjunctival scarring, improved patient comfort and in some
cases, earlier visual recovery [50-52]. Although this is true for most vitrectomy applications, it
is especially true for macula surgery including ERM peeling.
Small gauge systems are considered to offer better postoperative comfort due to minimal
surgical trauma. However, as size goes down, instruments tend to be less stiff, sometimes
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rendering globe manipulation during surgery difficult. Postoperative leakage from the
unsutured entry sites has been correlated to hypotony and endophthalmitis; however, the
findings in the literature regarding this are not consistent [48, 50, 53-54]. Moreover, as the small
cutter lumen removes smaller vitreous quantities per cut, vitreous removal is relatively slower
compared to traditional vitrectomy. Recent advances in vitrectomy systems related to fluidics,
cutting rates, instrument design and alloys, have succeeded in compensating for most of these
drawbacks and have made microincision vitrectomy systems the preferred platform for most
posterior segment surgeons. The introduction of xenon and mercury vapour lights has also
helped in overcoming some early problems related to illumination. The bright illumination
and low light hazard offered by these light sources, even in very small diameter systems, have
helped to broaden the scope of small gauge vitrectomy.
5.1.2. Visualization systems
Extremely clear visualization of the surgical field represents one of the cornerstones of modern
retinal microsurgery. Dealing with fine tissues and transparent membranes, and avoiding
damage to sensitive structures, requires a very good stereoscopic view. Several systems have
been introduced in surgical practice; below, the most commonly used are reviewed.
5.1.2.1. Contact lenses
Plano-concave lenses are placed directly on the cornea for posterior segment view. Their
primary advantage is the high-resolution image that the surgeon obtains with their application.
However, they have an important disadvantage in the form of their instability during surgery.
In order to overcome this limitation, ring systems have been designed for sutureless stabili‐
zation on the cornea; at the same time, various ways have been proposed for adjusting them
(e. g., on the speculum, at the cannulas etc.). Many surgeons use these lenses either separately
or in combination with a non-contact system.
5.1.2.2. Non-contact systems
The first non-contact optical system for visualizing the posterior segment was presented in
1987, which was the binocular indirect ophthalmomicroscope (BIOM, Oculus, Wetzlar,
Germany) [55]. It is the most frequently used wide-angle viewing system for retinal surgery.
The BIOM, as all other non-contact systems, is based on indirect ophthalmoscopy, which
results in an inverted image. An optical system introduced in the microscope’s optical pathway
is used for image re-inversion, so that the image viewed by the surgeon has normal orientation.
An important feature of the BIOM is the variety of lenses that one can choose from and switch
between during surgery, as it comes with a 60 deg., 90 deg. and 120 deg. refraction lens. For
example, for macular surgery, a 60 deg. macula lens can be placed for the membrane peeling,
while at the end of the procedure, the surgeon can switch to a 120 deg. wide field in order to
check for breaks at the periphery. In first BIOM generations, the focus and the inversion of the
field were manual; however, most recent BIOMs have incorporated a footswitch for focus
adjustment and an automated inverter.
Other non-contact systems include the EIBOS (HS, Moeller-Wedel Optical GmbH, Wedel,
Germany), the OFFISS (optic fibre free intravitreal surgery system/OFFISS; Topcon Medical
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Systems, Oakland, NJ), the OptiFlex (Volk, Mentor, OH), the PWL (PWL; Ocular Instruments,
Bellevue, WA) and the Resight 700 (Carl Zeiss Meditec AG, Jena, Germany). Each of them has
positive (automatic inverters, adjusted illumination, automatic lens switches, etc.) and
negative (adjustable in specific microscopes, unstable coaxiality, etc.) aspects. Eventually, the
selection of the particular optical system will depend on the surgeon’s experience, comfort and
familiarity with the technique and the technology.
5.1.3. Visualization adjuvants
Vital dyes stain the faint epiretinal membranes and thus improve contrast during surgery.
Their utilization has considerably facilitated macular surgery and is considered by many
surgeons extremely helpful for both ERM and ILM removal [56]. Trypan Blue (TB) is the most
frequently used dye and stains mainly the ERM. Brilliant Blue G (BBG) stains both the ILM
and ERM and is preferred when ILM removal is also desired. Other dyes such as indocyanine
green (ICG) and infracyanine green (IFCG) primarily stain the ILM and we will not discuss
their use in this chapter.
The use of trypan blue for ERM staining has been well-studied and is considered an excellent,
non-toxic approach for visualizing the membrane [57-59]. It is usually injected under air in
order to avoid lens capsule staining; this will hinder the continuation of the operation due to
the deprivation of the view of the posterior segment. Alternatively, heavy TB can be used,
which does not demand an air-fluid exchange [60]. The TB is left for one- to three-minutes and
is then washed away. The epiretinal membrane and other proliferative tissue are stained and
their edges show against the unstained background.
Brilliant Blue G mostly stains the ILM, but the ERM is also stained to some degree [61]. It is
preferred when dual staining is necessary, for simultaneous removal of ERM and ILM [62]. It
is also injected under air and washed away after a few minutes. It is generally reported to be
safe although some concerns about retinal toxicity have been raised [59, 63-64].
Another substance that is quite effective in visualizing ERMs is triamcinolone (TA). TA is not
a dye; it forms crystals that are deposited through loosely organized collagen matrices, making
visible the vitreous body, but also ERMs and the ILM [65].
5.1.4. Forceps and scissors
Fine instruments are imperative for handling fine structures such as the epiretinal membranes
and the ILM to lessen possible damage to the underlying retinal tissue. Instrument sizes follow
the trend of minimizing the size of the vitrectomy ports. Nowadays, forceps, scrapers, scissors
and other adjuncts exist in compatibility with 20g, 23g, 25g and 27g PPV systems.
End-grasping forceps are the most commonly used instruments for ERM peeling. Klaus
Eckhardt developed the first fine end-grasping forceps in the 90s; these proved to be very
effective and are still preferred today. Later, Charles developed conformal forceps, meaning
that they have the same radius of curvature as the retina and avoid grasping of the retinal
surface by grasping the nerve fibre layer (NFL) during the procedure. Rarely, in high adherence
situations, scissors can be used. Horizontal scissors are preferred because of their safer profile
compared to vertical scissors. They can be inserted into the potential space between the
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membrane and the retina, with both blades more efficiently delaminating the ERM from the
subjacent tissue.
When the edge of the membrane is not easily grasped by forceps, a Tano diamond dusted
membrane scraper (DDMS) can be used. This tool is coated with inert diamond dust that makes
traction easier and offers an atraumatic alternative to finding the edge of the membrane due
to its soft silicon tip. The Tano DDMS is for some surgeons an indispensable part of macular
surgery. Its use is also suggested for ILM removal. However, attempting to create an edge at
the ILM with this tool is strongly discouraged due to the damage it can cause to the subjacent
tissue [66].
5.2. Removal technique
Once the vitrectomy is completed, the ERM is inspected for visible edges. Existing edges are
visualized much better if dye has been used for ERM staining. Moreover, careful preoperative
evaluation using SDOCT can be extremely helpful in this regard by providing information
about the 3D configuration of the membrane and the selection of an optimum area for peel
initiation. If a pre-existing edge cannot be found, it can be created using a pick or a micro-
vitreoretinal (MVR) blade. The edge is then grasped with the forceps, with the one blade on
the anterior surface and the other under the membrane, and a circumscribed flap is created.
Then, careful and gentle dissection is started from the periphery to the centre of the membrane
(outside-in technique), similar to the capsulorhexis in cataract surgery. Alternatively, the
membrane is grasped centrally and peeled away from the centre, always in a circumferential
pattern (inside-out technique). Some surgeons consider the inside-out technique safer, because
the central retina is thicker and stronger, making it easier for the surgeon to find a tissue plane
to begin with.
Since both the picking and the grasping of the membrane can cause damage to the subjacent
retinal tissue (tears, bleeding, ischaemia), good visualization and controlled manoeuvres are
very important at this stage. Directing the tip tangentially to the retinal surface and engaging
the membrane from different directions helps to avoid fragmentation of the tissue sheet and
inadvertent tearing of the retina [67].
Charles has proposed an alternative approach for minimizing tissue damage, described as
“pinch peeling”. In this case, the forceps pinch the membrane without creating an “edge” and
grasp it with the two blades on the surface of the membrane. Retinal contact is thus avoided
and the risk of retinal damage is minimized [68].
5.2.1. ILM peeling
Very often, the ILM is peeled off together with the ERM. This can be monitored during ERM
peeling by using a dye that stains both the ERM and the ILM, e. g., Membrane Blue Dual®
(DORC, Japan). If this is not achieved, the ILM can be removed at a second step. ILM peeling
is impossible without the creation of an opening in the inner limiting membrane. If an edge of
the ILM has not been created during ERM manipulation and removal, it can be made using a
pick or MVR blade, at a location away from the maculo-papillary bundle, frequently along the
temporal horizontal raphe. The fine-end forceps are again used to grasp and elevate the
membrane and peeling is again performed in a circular motion, extending towards the vascular
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arcades. The simultaneous removal of the ILM is imperative for some surgeons, but it is not
yet clear whether it affects recurrence rates [69-70] or retinal function [71-73].
5.3. Conclusion of surgery
Following ERM removal, inspection of the peripheral retina follows; if this shows no iatrogenic
damage, surgery is completed by trocar removal and sclerotomy closure. If iatrogenic damage
is present, breaks in the periphery without subretinal fluid accumulation can be treated by
laser retinopexy or cryoretinopexy. The presence of significant amounts of subretinal fluid
necessitates internal drainage, retinopexy and gas tamponade.
Although scleral ports in small gauge vitrectomy are designed so that no sutures are necessary,
careful inspection of the water tightness of the ports at the conclusion of surgery is mandatory
in order to avoid early postoperative hypotony. Gentle massage of the site of scleral incision
after trocar removal can improve a relatively leaky incision. Occasionally, the insertion of a
small suture may be necessary for a leaky scleral incision.
6. Results and prognosis
6.1. Functional results
In general, visual acuity seems to improve following ERM surgery. More than 50% of patients
gain 2 or more logMAR lines and less than 10% end up with lower postoperative VA [74-76].
Preoperative vision is usually 20/63 or worse, but cases with good visual acuity have been
reported to benefit from surgery, too [77]. Improvement in vision usually occurs in the first
two to three months, but complete recovery may require six to 12 months following surgery.
Additionally, cataract extraction is very likely to be needed shortly after ERM peeling, as
nuclear sclerosis accelerates after vitrectomy [75, 77-79].
Overall, visual prognosis depends on preoperative vision, the duration of symptoms and the
preoperative anatomical status of the fovea and retinal layers [74, 80]. Postoperative BCVA is
better in patients with good preoperative VA, but the gain in letters seem to be greater for
patients with poorer preoperative VA. This means that patients with low preoperative visual
acuity do not enjoy complete recovery after macular membrane removal. Limited restoration
of the VA in these patients can be due to chronic traction, which results in permanent retinal
vascular incompetence. Subsequent retinal vascular leakage and persistent cystoid macular
oedema restrict the restoration of macular function and anatomy.
Metamorphopsia, one of the main reasons for patients deciding to undergo surgery, has not
been investigated in a methodical and quantified manner. In the few studies that have studied
metamorphopsia, it appears to improve after surgery and can happen as early as the first
postoperative month [81-82]. Its preoperative existence affects postoperative visual outcomes,
but the duration of preoperative symptoms do not affect the postoperative visual acuity three
months after surgery [81].
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6.2. Anatomical outcome
Postoperative reduction of the central macular thickness (CMT) has been a consistent finding
in most studies [75, 83]. Figure 2 shows the anatomic restoration of the fovea (b) and following
the removal of the epimacular membrane (a) in one of our cases, six months postoperatively.
Visual recovery, however, is not always correlated with the decrease of retinal thickness.
Recent studies have correlated other preoperative and postoperative anatomical features with
visual outcomes. OCT represents an invaluable tool for the assessment of these features,
primarily by using high definition techniques. Ellipsoid zone (IS/OS) integrity, photoreceptor
outer segment (PROS) length and external limiting membrane (ELM) integrity represent some
of the anatomical characteristics that appear to play an important role in functional prognosis.
Significant changes in ellipsoid integrity (IS/OS) have been correlated with visual outcomes,
while postoperative elongation of the PROS have been described in successful cases [84].
Figure 2. Anatomical restoration after ERM peeling; a) preoperative image of contracted ERM with retinal thickening
and cystoid macular oedema; b) six months after surgery the foveal anatomy has greatly improved. Small intraretinal
cysts can still be seen along with some changes in the outer retinal layers.
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On the other hand, although postoperative visual field loss is known to occur in some cases
following ERM surgery, its correlation with anatomical changes in the OCT has not been
confirmed by the literature. The effect of surgery on the nerve fibre layer (NFL) and the
ganglion cell layer (GCL) are under intense investigation, especially with “en face” OCT and
other sophisticated techniques. However, the results on whether there is loss of neuronal or
glial tissue remain ambiguous, as do reasons for the late deformation of the central retina, often
observed following ERM surgery. Based on modern retinal imaging modalities, it is believed
that retinal reconstruction continues for months after ERM peeling [85-86].
6.3. Prognosis of different ERM subtypes
Secondary epiretinal membranes have worse prognosis than idiopathic membranes [69].
Limited visual recovery, as well as higher recurrence rates, is reported. Diabetic membranes
are difficult to manage, as they are accompanied by severe retinal damage that can lead to
serious complications including haemorrhage, detachment and re-proliferation of the connec‐
tive tissue [87]. Postoperative ERMs (including ERMs developed after vitrectomy for retinal
detachment, but also after laser or cryo-retinopexy) have limited visual recovery, especially
when the macula is detached [88]. Finally, inflammatory membranes illustrate variable results,
depending mostly on the effect of the subjacent inflammation on the retinal function [89].
7. Complications
Epiretinal membrane removal is generally a safe procedure. Intraoperative complications
involve retinal breaks, retinal haemorrhage, retinal whitening and retinal surface damage.
Postoperative complications include cataract formation, rhegmatogenous retinal detachment
(RRD), cystoid macular oedema, endophthalmitis and the recurrence of fibrotic tissue.
A common intraoperative complication is the creation of iatrogenic retinal breaks. These occur
during vitrectomy; thus, careful examination of the periphery with indentation at the conclu‐
sion of surgery is crucial for their early/prompt diagnosis. Their treatment is straightforward,
that is, through the application of intraoperative laser retinopexy or cryopexy. However, a
break can also occur at the posterior pole (due to pinching or during the dissection of a high-
adherent membrane) and in this case, laser treatment may be hazardous to the fovea and
should be performed with caution.
Haemorrhage at the site of pinching or grasping or at the area where the membrane detaches
from a retinal vessel is also common. In this case, recovery is usually short and uneventful.
More extensive bleeding may occur less often when a vessel is damaged during the dissection
and can be controlled by increasing intraocular pressure or intraoperative cautery.
Retinal whitening is the result of ischaemia that usually resolves intraoperatively; nevertheless,
sometimes it may persist for an extended period of time. Membrane manipulation can also
cause surface tissue damage, which may or may not be symptomatic. Symptoms involve
primarily visual field defects and one should differentiate if these are due to tissue deficits or
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ischaemia. In the first case, direct damage may be the result of pinching or gripping of the
membrane; additionally, indirect damage to the inner retina can occur if ILM peeling had been
part of the surgical procedure.
The most frequent postoperative complication of ERM surgery is the progression of nuclear
sclerosis of the crystalline lens. Most often, visual acuity improves during the first six to nine
months, but then slowly decreases as the cataract develops. The majority of phakic patients
undergo cataract extraction within two years in order to maximize the benefits of the initial
operation. For this reason, some surgeons prefer a combined operation of phacoemulsification,
ERM peeling and IOL implantation [74-76, 90].
Rhegmatogenous retinal detachment is another important postoperative event. The cause in
this case is usually a peripheral break caused by traction or incarceration of vitreous in the
sclerotomies and demands surgical treatment.
Recurrence of ERMs may be seen in up to 5% of eyes with idiopathic membranes. Younger
individuals, patients with a prior history of retinal detachment and patients with a prior
history of uveitis tend to have a higher recurrence rate, which in some studies have been
up to 12% [71].  Remarkably,  recurrence is  reported to be higher by many studies when
ILM is left intact [69, 91].
Endophthalmitis is quite rare after standard 20g vitrectomy (0.02 to 0.14%) [92]. For transcon‐
juctival sutureless vitrectomy (TSV) and especially when using the 25g system, higher rates
have been reported (0.04 to 1.55%) [92]. Nevertheless, this finding has not been conclusively
confirmed in the literature; thus, the question regarding the increased risk of infection after
TSV is yet to be clarified [93-97].
8. Surgery vs. observation
Despite the favourable results of surgery for the treatment of ERM, debate remains regarding
a preferable treatment strategy. Decision for surgery and selection of the proper method
depends on the surgeon’s preference and on the patients’ characteristics. Nevertheless, it is
highly significant to perform meticulous patient selection for each method in order to achieve
better outcomes with regard to patients’ overall visual ability and quality of life.
As discussed above, interventional studies indicate that early surgical removal can relieve
disturbing symptoms and stabilize vision, which may worsen later [74-77, 81-82]. This is in
contrast with the fact that ERMs do not always progress and may be stable during follow-up
without any intervention [35, 98]. Moreover, there are possible side effects to surgery and the
improvement in visual acuity is greater in patients with preoperative lower visual acuity.
In the paragraphs that follow, we will attempt to review data from the literature concerning
surgery timing and patient selection.
Epidemiological population-based studies suggest that a large percentage of cases diagnosed
with ERM may remain stable during follow-up. These studies agree that the disease is non-
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progressive in a significant percentage of cases and also that regression may be observed
without any intervention. In the Blue Mountains eye study, 28.6% of cases experienced
progression, 38.8% of eyes remained stable and 25.7% of cases regressed in a five-year follow-
up period [35]. In a prospective cohort study of 1932 patients undergoing cataract surgery, it
was reported that 43% of patients progressed postoperatively after one month had passed
during a 36-month follow-up, 32.4% of patients remained stable and 24.6% of patients
regressed [98]. According to these results, similar percentages of patients with cellophane
maculopathy and patients with preretinal fibrosis progressed; additionally, the regression
rates in both groups were similar: 26% of cellophane reflex cases and 18% of preretinal fibrosis
cases regressed spontaneously without surgical intervention. Of the 14 cases of preretinal
fibrosis regression, five cases had complete regression, while the rest had partial ERM
regression. In the Blue Mountains study, regression rates were similar in the cellophane
macular reflex (CMR) group and in the preretinal macular fibrosis (PMF) group (25.7% and
25.8%, respectively). Regarding progression, 16.1% of participants with PMF at baseline and
32.8% of patients with CMR at baseline progressed, including 17 eyes in which CMR pro‐
gressed to PMF (9.3%). There was no significant association between the ocular and systemic
risk factors detected for predicting the progression of preretinal macular fibrosis during the
five-year follow-up [35]. It appears that according to these prospective cohort studies,
progression of ERM affected about a third of patients; furthermore, a small amount of patients
regressed completely. The differences in percentages among studies can be attributed to the
different criteria selected for progression and regression, as well as to the different study
populations.
Based on these data, a follow-up period prior to making a decision for surgery was imposed
in most cases, depending on the amount of visual disturbance upon diagnosis.
Regarding visual acuity, in the Blue Mountains study, the authors demonstrated that the
level of mean visual acuity was only slightly affected by incident preretinal macular fibrosis
and was unaffected by incident cellophane macular reflex. The average reduction of visual
acuity after five years in the worst eyes was 5.7 letters (CI, 5.3 to 6.1) in subjects without
incident epiretinal membranes, 7.4 letters (CI, 4.7 to 10.1) in eyes with incident preretinal
macular fibrosis and 2.8 letters (CI,  1.6 to 4.0)  in eyes with incident cellophane macular
reflex. Corresponding mean differences in visual acuity between the baseline and a five-
year  examination were not  statistically  significant  [35].  Thus,  surgery was not  promptly
needed with regard to visual acuity, since the progression of vision loss, if any, was very
slow.  When surgery  is  undertaken in  cases  with  significantly  impaired visual  acuity,  it
provides improvement more frequently and to a greater extent than in eyes with better
preoperative visual acuity [79].
On the other hand, eyes with lower preoperative visual acuity tend to have lower final visual
acuity, whereas the final visual prognosis is better for eyes with better preoperative visual
acuity [79, 99]. Studies using spectral domain optical coherence tomography have shown that
visual disturbance induced by ERM is associated with intraretinal changes, including the
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disruption of photoreceptor integrity. These findings suggest that the damage resulting from
ERMs is partially irreversible, regardless of surgical management. Consequently, from this
point of view, an early intervention prior to the induction of permanent damage seems more
rational.
In order to make the decision for undergoing surgery, it is important to evaluate the prognosis
of surgery in each case. Preoperative evaluation with time-domain OCT (TDOCT) and spectral-
domain OCT (SDOCT) has given us the ability to assess morphologic features that correspond
to intraretinal tissue damage and its association with preoperative visual symptoms, and to
evaluate the potential for improvement [81, 100-103]. According to clinical studies with
TDOCT and SDOCT, the preoperative disruption of the photoreceptors’ inner and outer
segment junction (ellipsoid zone, IS/OS) is one of the main prognostic factors. Suh et al. and
Falkner-Radler et al. compared TDOCT in ERM patients pre- and post- vitrectomy and found
that eyes experiencing disruption of the ellipsoid zone had significantly lower postoperative
best corrected visual acuity (BCVA) and lower BCVA differences when comparing pre- and
post-surgery conditions, compared to those without preoperative OCT disruption [81, 100].
The latter study additionally confirmed the predictive value of ellipsoid zone integrity for
postoperative functional outcomes with SDOCT [100]. Inoue et al. and Kim et al. prospectively
allocated their patients based on preoperative ellipsoid zone integrity in groups of intact versus
disrupted and found that the intact ellipsoid zone cohort had better final visual acuity and
better improvement in visual acuity. The predictive role of the preoperative central foveal
thickness, the presence of a macular pseudohole or the presence of retinal cysts was not
confirmed in these studies [101-103].
Other factors that may predict visual outcome and affect decisions regarding surgery are the
presence of any other macular co-morbidity such as age-related maculopathy. The length of
the photoreceptor outer segment and the thickness of the inner retinal layer are also correlated
with visual function, and might therefore be useful in predicting surgical outcomes [103].
Additionally, as mentioned earlier, the presence and severity of metamorphopsia has also been
correlated with final visual outcomes [81-82].
9. Conclusion
Vitrectomy and membrane peeling is currently the preferred surgical treatment option for eyes
with ERM. However, no consensus has been established concerning an optimal time for
surgery. Early intervention may prevent the evolvement of non-reversible damage to the outer
retina; however, ERM progression concerns only a small percentage of patients. Follow-up
with SDOCT and clinical examination for recording visual acuity and metamorphopsia is
imposed in early cases prior to decision-making. Moreover, in more advanced stages, the
application of SDOCT for assessing retinal integrity and predicting postoperative outcomes is
necessary in order to predict possible functional gain following surgery.
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